Kirsten H.
- Country
- Germany
- Department
- Arztpraxis für Neurologie und Psychatrie
Research Overview
- Phase 2/3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of EXV-802 and EXV-801 in Participants with Agitation in Alzheimer’s Disease
- Long-term Evaluation of NMRA-335140 for Safety and Efficacy in Major Depressive Disorder Patients
- Evaluation of NMRA-335140 Efficacy in Major Depressive Disorder: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 66 of 273 partner sites.
Specializations
Neuropsychiatric Disorders
The investigator specializes in treating major depressive disorder (MDD), with particular focus on innovative therapeutic approaches and treatment-resistant cases. Their research encompasses both standard and adjunctive therapy options for depression management.
- Depression with anhedonia
- Long-term depression management
- Novel antidepressant therapies
A significant portion of their work involves evaluating new therapeutic compounds for depression treatment, including kappa opioid receptor antagonists.
Cognitive Disorders
The investigator conducts research in Alzheimer's dementia and associated behavioral symptoms. Their work focuses on managing complex manifestations of dementia, particularly agitation in Alzheimer's patients.
- Behavioral symptoms in dementia
- Agitation management
- Cognitive impairment interventions
Their expertise extends to evaluating novel therapeutic approaches for behavioral and psychological symptoms of dementia.
Neurodevelopmental Conditions
The investigator focuses on adult Attention Deficit Hyperactivity Disorder (ADHD) and schizophrenia treatment modalities. Their research includes evaluation of various drug delivery systems and therapeutic approaches.
- Adult ADHD management
- Schizophrenia interventions
- Cognitive improvement strategies
They explore both immediate-release and modified-release formulations for neurodevelopmental disorders, along with adjunctive treatments for schizophrenia.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.